Please note: If you have a promotional code you'll be prompted to enter it prior to confirming your order.

Customer Sign In

Returning Customer

If you have an account, please sign in.

New Customers

If you subscribe to any of our print newsletters and have never activated your online account, please activate your account below for online access. By activating your account, you will create a login and password. You only need to activate your account once.

In Case You Missed It:

Harvard Medical School

Harvard Medical School is part of Harvard University. The goal of all Harvard Medical School publications is to bring the public, around the world, the most current practical, authoritative health information, drawing on the expertise of the 8,000 faculty physicians at the Harvard Medical School and its world-famous affiliated hospitals.

Prostate Knowledge — Advisory Board

MARC B. GARNICK, M.D., EDITOR IN CHIEF, is an internationally renowned expert in medical oncology and urologic cancer. He is the Gorman Brothers Professor of Medicine at Harvard Medical School and the Beth Israel Deaconess Medical Center, where he also maintains an active clinical practice. He has dedicated his career to the development of new therapies for prostate cancer. The Annual Report on Prostate Diseases, formerly Perspectives on Prostate Disease, emerged from Dr. Garnick’s keen interest in explaining issues of medical importance to patients and their families to help them select appropriate treatments. He has authored numerous scientific articles and reviews on clinical research, drug development, and cancer biology, and has written or edited six books, including A Patient’s Guide to Prostate Cancer. He served as the initial academic principal investigator for the commonly used prostate cancer drug leuprolide (Lupron). In addition to his academic affiliations, Dr. Garnick founded the Hershey Family Foundation for Prostate Cancer Research at Beth Israel Deaconess Medical Center, serves as medical adviser to World Book Encyclopedia, and is an active advisory member of several FDA panels and advisory committees. He has served on the boards of trustees of the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine. Dr. Garnick is also a trustee emeritus of Bowdoin College in Brunswick, Maine.

PER-ANDERS ABRAHAMSSON, M.D., PH.D., is the immediate past secretary general of the European Association of Urology, the leading professional organization overseas. He is also the former chair of the Department of Urology at Lund University Hospital in Malmö, Sweden. The author of numerous scientific publications, he serves on the editorial board of several scientific journals. He has received a number of national and international awards, and is the organizer of international conferences that bring physicians together from multiple disciplines.

WILLIAM C. DEWOLF, M.D., is a professor of surgery (urology) at Harvard Medical School and chief of the Division of Urology at Beth Israel Deaconess Medical Center in Boston. Dr. DeWolf is a past member of the editorial board of Urology and is the author of numerous original reports, abstracts, and review articles published in peer-reviewed journals. A member of many professional societies, Dr. DeWolf has pursued such areas of research as the identification of urinary biomarkers for prostate cancer and the molecular biology of prostate cancer.

RAVI KACKER, M.D., is a urologist and part-time instructor at Harvard Medical School. He is an active scientific researcher with several publications in the areas of testosterone, prostate and testicular cancer, enlarged prostate/BPH, and kidney stone disease. His clinical interests center on low testosterone and metabolic disease, erectile dysfunction, pelvic and testicular pain, prostate cancer, and lower urinary tract symptoms.

IRVING KAPLAN, M.D., is an assistant professor of radiation oncology at Harvard Medical School and a staff radiation therapist at Beth Israel Deaconess Medical Center. His research interests include image-guided radiation therapy, brachytherapy, and molecular predictors of tumor response. In addition to publishing widely in the area of prostate disease, he is a member of the Kidney Cancer Program and the Prostate Cancer Program at the Dana-Farber/Harvard Cancer Center.

KEVIN R. LOUGHLIN, M.D., M.B.A., is a professor emeritus of surgery (urology) at Harvard Medical School. He has served as a trustee and vice president of the American Board of Urology and as the New England section representative to the American Urological Association board of directors. His clinical interests include urologic oncology and urinary incontinence. He has published over 250 articles in scientific journals and has served on multiple editorial boards. He is the author or co-author of several books, including 100 Questions & Answers About Benign Prostate Disease and the Clinical Guide to Prostate Specific Antigen.

MIGUEL SROUGI, M.D., PH.D., is a professor of urology at the University of São Paulo Medical School and director of the Urology Division of the Hospital das Clínicas, University of São Paulo Medical School. He has written nearly 600 research articles and over 180 book chapters focused on prognostic factors and natural history of urologic cancers and their surgical treatment. Dr. Srougi has received 58 awards and honors in the medical field, including the Conrado Wessel Prize of Medicine in 2011. He was included on a list compiled by Época magazine of the 100 most influential Brazilians in the years 2012 and 2013.

CORA N. STERNBERG, M.D., F.A.C.P., is Professor of Oncology and Chief of the Department of Medical Oncology at the San Camillo–Forlanini Hospital in Rome and adjunct professor at La Sapienza University, in Rome, and Tufts University School of Medicine in Boston. Principal investigator for numerous studies and an internationally respected researcher, Dr. Sternberg received the 2013 ESMO Award from the European Society for Medical Oncology. She has served as the scientific coordinator of many international conferences and is the lead author of many journal articles. In addition, Dr. Sternberg has written or co-edited several medical textbooks.

ANTHONY L. ZIETMAN, M.D., is the Jenot and William Shipley Professor of Radiation Oncology at Harvard Medical School and a radiation oncologist at Massachusetts General Hospital. A past chair of the American Society for Radiation Oncology, Dr. Zietman is a former trustee of the American Board of Radiology. His research interests include the roles of active surveillance, brachytherapy, hormone therapy, and proton beam therapy in the treatment of prostate cancer. Dr. Zietman has authored many articles and reviews on various aspects of genitourinary cancer. He is now the editor in chief of the International Journal of Radiation Oncology, Biology, Physics.

Source: 2018 Annual Report on Prostate Diseases

Welcome Message

Learn more about this site in a welcome video from Dr. Marc Garnick, editor in chief.

Prostate Resources

Disclaimer

The contents displayed within this public group(s), such as text, graphics, and other material (“Content”) are intended for educational purposes only. The Content is not intended to substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your healthcare provider with any questions you may have regarding your medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in a public group(s).

If you think you may have a medical emergency, call your healthcare provider or 911 immediately. Any mention of products or services is not meant as a guarantee, endorsement, or recommendation of the products, services, or companies. Reliance on any information provided is solely at your own risk. Please discuss any options with your healthcare provider.

The information you share, including that which might otherwise be Protected Health Information, to this site is by design open to the public and is not a private, secure service. You should think carefully before disclosing any personal information in any public forum. What you have written may be seen, disclosed to, or collected by third parties and may be used by others in ways we are unable to control or predict, including to contact you or otherwise be used for unauthorized or unlawful purposes. As with any public forum on any site, this information may also appear in third-party search engines like Google, MSN, Yahoo, etc. Your use of this site is governed by Harvard University and its affiliates Terms of Use located at www.health.harvard.edu/privacy-policy
and may be amended from time to time.

View Less

The contents displayed within this public group(s), such as text, graphics, and other material (“Content”) are intended for educational purposes only. The Content is not intended to substitute for professional medical advice, diagnosis, or treatment. . . .